DelveInsight's Amyotrophic Lateral Sclerosis Market Insights report includes a comprehensive understanding of current treatment practices, amyotrophic lateral sclerosis emerging drugs, market share of ...
PLANEGG-MARTINSRIED, Germany and AMMAN, Jordan, Dec. 4, 2025 /PRNewswire/ -- Formycon AG (FSE: FYB, Prime Standard) and MS Pharma jointly announce that they have entered into an exclusive licensing ...
The new patent granted in South Korea is added to earlier patents already granted by the United States Patent and Trademark Office (USPTO), Europe, Canada and other jurisdictions and will expire in ...
AFTER AMERICA, China is the world’s largest developer of new medicines. Its companies ran nearly a third of the planet’s clinical trials last year. That is up from just 5% a decade before (see chart 1 ...
RANCHO CUCAMONGA, CA / ACCESS Newswire / November 24, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO, and Tony Marrs, EVP of Regulatory Affairs and Clinical ...
MIAMI — An emotional Megan Thee Stallion told a court Thursday she feels "defeated" and struggles with mental health issues because of sexually explicit deepfake video a blogger is alleged to have ...
SCHAUMBURG, Ill., Dec. 3, 2025 /PRNewswire/ -- Sagent Pharmaceuticals ("Sagent"), a leading provider of injectables to the U.S. market, is excited to announce a strategic partnership with Provepharm ...
The official logo of the upcoming National Youth Day in the Caceres archdiocese reflects what they’ve been through following the recent storm that devastated the Bicol region. Unveiled recently, the ...
The U.S. health regulator has approved GSK's add-on treatment for severe asthma, offering a less frequently dosed option, but rejected its use for another condition, the drugmaker said on Tuesday.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results